An R & D focus allows the flexibility to collaborate with companies that specialize in products that would aid in further developing cannabinoid research.

Testing their products through the execution of well-designed experiments, we can achieve reproducible scientific data and publish our findings, thus endorsing a product that provides benefits, to the Licensed Producers and to the medical marijuana industry, as a whole.

Product development partnerships would be initiated with businesses that focus on:

  • Soil
  • Fertilizer
  • Seeds
  • Pesticides or natural products that are pest repellents and do not currently meet regulatory standards
  • Air quality equipment
  • Lighting
  • Analytical testing
  • Harvesting equipment
  • Growth model chambers
  • Medical devices

Benefits of product development partnerships include:

  • Innovative growth and harvest information
  • Standardized production techniques
  • Accurately gauged costs of experimentation, production and third party analytical testing
  • Scientific and biotechnological support services that are fully customized and unique for every client

We intend to establish collaborations to develop efficient medications that pass rigorous Quality Assurance requirements, provide effective and regulated doses and improve upon current available delivery methods. Potential partners in these collaborations would be:

  • Pharmaceutical companies
  • Non-profit and patient organizations
  • Doctors and clinical groups
  • University researchers

MMPR News & Updates

THC BioMed (CSE: THC) Closed Acquistion of U.S. based Clone Shipper LLC

May 9th, 2017|Comments Off on THC BioMed (CSE: THC) Closed Acquistion of U.S. based Clone Shipper LLC

THC Announces Purchase of Clone Shipper LLC

May 8th, 2017|Comments Off on THC Announces Purchase of Clone Shipper LLC